Smith & Nephew Share Discussion Threads

[justiceforthemany] 21/3/2024 16:39

This stock is completely out of favour.
CEO needs the boot.

[cerrito] 06/3/2024 13:38

Interested to read this in Citywire
quote
he market has an ‘unconscious bias’ against Smith & Nephew (SN) and always assumes the worst about the medical technology company, says Liberum.

Analyst Seb Jantet retained his ‘buy’ recommendation and target price of £12.85 on the Citywire Elite Companies AA-rated provider of hip and knee implants, which rose 0.3% to £10.46 on Tuesday.

‘We are slightly perplexed by the market’s reaction to Smith & Nephew’s full-year results,’ Jantet said.

‘Trading was in line and there was a solid guide for full year 2024. And while the initial share price reaction was positive, the shares fell sharply over the next few days.

‘Understandable given Smith & Nephew’s track record, but it is this unconscious bias that is creating an interesting disconnect between the valuation and the fundamentals,’ said Jantet.

He added that ‘both the revenue and margin guides are achievable’ and said the ‘discount to peers is too high’.

[justiceforthemany] 01/3/2024 16:42

So who's bothered to contact the CEO?
If you're a stakeholder you certainly should.

[justiceforthemany] 29/2/2024 17:46

CEO is on very thin ice here. Has been for a while. The discount to peers like Stryker is stark, assuming EPSA for 2024 comes in around 85c; 15x P/E.
Despite the Covid backlog shares remain super depressed and half their pre covid value.
CEO email below
[e-mail]

[essentialinvestor] 29/2/2024 12:41

Bought s small amount.

[lonrho] 28/2/2024 23:21

Smith and nephew price about 13 dollars ,stryker 350 dollars so maybe no .

[pdriccio] 28/2/2024 21:25

Stryker eps 8.25 dollarsS.N eps 0.828 centsSo maybe, yes.

[justiceforthemany] 28/2/2024 17:49

Stryker trades at 35x earnings.
This stock at 15x earnings.
Fair?

[dope007] 28/2/2024 09:15

Haha. Gone well that one. As has Hunting

[suetballs] 28/2/2024 09:04

Come on Dope you got bab right - time you got in here!
Suet

[dope007] 28/2/2024 08:44

Getting tempted here as the UK mkt continues to perform awfully

[justiceforthemany] 27/2/2024 16:14

This used to trade at 20-25x earnings.
Now down at 15x
Appears bids for the company have been and are being with held IMO.

[suetballs] 27/2/2024 12:00

Eek. Presumably peeps selling on the rise.
Suet

[edwardt] 27/2/2024 08:41

bit of a relief those results. 20% margin target re-affirmed. just maybe we could be onto a decent recovery here.

[edwardt] 31/1/2024 17:36

stryker smashed it.

[philanderer] 18/12/2023 00:40

Exactly ; pinch of salt. They all talk their own book.

[shabirm] 17/12/2023 22:56

Do UBS and Goldman know what they are talking about with target price differential of neay 30% from current share price. That says a lot about professional analysis.

[philanderer] 15/12/2023 15:56

or........

UBS cuts Smith & Nephew price target to 1,090 (1,150) pence - 'neutral'

[philanderer] 10/11/2023 11:07

Goldman Sachs starts Smith & Nephew with 'buy' - price target 1,400 pence

[keyno] 02/11/2023 13:27

Suet: I agree re undervaluation. We live in hope.

[essentialinvestor] 02/11/2023 12:21

Justice, so around £9 was a decent entry - you can thank me later ;

[chrisdgb] 02/11/2023 12:19

Still got an awful long way to rally, cost savings look good for the margin..........

[justiceforthemany] 02/11/2023 12:07

Why was it allowed to crash 30% in a month? Just because a hedge fund opened a short?
Corrupt market.

[suetballs] 02/11/2023 11:20

Yep - that's a bit better.
IMO this is still very undervalued.
Shorters heading for the hills?
Suet